Osaic Holdings
BIO icon

Osaic Holdings’s Bio-Rad Laboratories Class A BIO Stock Holding History

Osaic Holdings’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Sell
2,801
-423
-13% -$120K ﹤0.01% 3201
2026
Q1 		$899K Sell
3,224
-80
-2% -$23K ﹤0.01% 2813
2025
Q4 		$1M Sell
3,304
-240
-7% -$74.9K ﹤0.01% 2692
2025
Q3 		$1.05M Buy
3,544
+167
+5% +$45.4K ﹤0.01% 2744
2025
Q2 		$815K Sell
3,377
-1,421
-30% -$336K ﹤0.01% 2688
2025
Q1 		$1.17M Sell
4,798
-1,619
-25% -$487K ﹤0.01% 2111
2024
Q4 		$2.11M Buy
6,417
+892
+16% +$303K ﹤0.01% 1616
2024
Q3 		$1.85M Buy
5,525
+1,529
+38% +$486K ﹤0.01% 1756
2024
Q2 		$1.09M Buy
3,996
+556
+16% +$162K ﹤0.01% 2134
2024
Q1 		$1.19M Sell
3,440
-5,658
-62% -$1.86M ﹤0.01% 2180
2023
Q4 		$2.94M Sell
9,098
-15,576
-63% -$4.88M 0.01% 1555
2023
Q3 		$8.84M Buy
24,674
+8,416
+52% +$3.25M 0.01% 924
2023
Q2 		$6.19M Sell
16,258
-33
-0.2% -$13.4K 0.01% 1031
2023
Q1 		$7.78M Buy
16,291
+558
+4% +$261K 0.01% 890
2022
Q4 		$6.61M Sell
15,733
-343
-2% -$138K 0.01% 934
2022
Q3 		$6.71M Sell
16,076
-707
-4% -$352K 0.02% 849
2022
Q2 		$8.32M Sell
16,783
-160
-0.9% -$83.3K 0.02% 763
2022
Q1 		$8.41M Sell
16,943
-2,865
-14% -$1.73M 0.02% 862
2021
Q4 		$14.9M Buy
19,808
+4,730
+31% +$3.54M 0.03% 535
2021
Q3 		$11.2M Buy
15,078
+196
+1% +$147K 0.02% 614
2021
Q2 		$9.63M Buy
14,882
+706
+5% +$430K 0.02% 666
2021
Q1 		$8.11M Buy
14,176
+3,305
+30% +$1.96M 0.02% 694
2020
Q4 		$6.34M Buy
10,871
+938
+9% +$534K 0.02% 724
2020
Q3 		$5.04M Sell
9,933
-587
-6% -$297K 0.02% 756
2020
Q2 		$4.75M Buy
10,520
+1,010
+11% +$446K 0.02% 726
2020
Q1 		$3.37M Buy
+9,510
New +$3.5M 0.01% 779

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Osaic Holdings's BIO Position: Q2 2026 in Review

Osaic Holdings reduced its Bio-Rad Laboratories Class A (BIO) stake by 13% in Q2 2026, selling an estimated $120K and leaving 2,801 shares worth $822K. The position accounts for ﹤0.01% of the portfolio, ranked #3201.

Osaic Holdings first reported a position in BIO in Q1 2020 and has held it in 26 quarters since. The position peaked at $14.9M in Q4 2021. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Osaic Holdings held 2,801 shares of Bio-Rad Laboratories Class A worth $822K as of Q2 2026.
  • Osaic Holdings sold 423 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $120K.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3201 holding.
  • Osaic Holdings first reported a position in Bio-Rad Laboratories Class A in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Bio-Rad Laboratories Class A position peaked at $14.9M in Q4 2021.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.